Department of Urology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Obstetrics, Gynecology, and Reproductive Sciences and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Fertil Steril. 2020 Mar;113(3):500-509. doi: 10.1016/j.fertnstert.2020.01.038. Epub 2020 Feb 25.
Since the birth of the first child conceived via in vitro fertilization 40 years ago, fertility treatments and assisted reproductive technology have allowed many couples to reach their reproductive goals. As of yet, no fertility options are available for men who cannot produce functional sperm, but many experimental therapies have demonstrated promising results in animal models. Both autologous (stem cell transplantation, de novo morphogenesis, and testicular tissue grafting) and outside-the-body (xenografting and in vitro spermatogenesis) approaches exist for restoring sperm production in infertile animals with varying degrees of success. Once safety profiles are established and an ideal patient population is chosen, some of these techniques may be ready for human experimentation in the near future, with likely clinical implementation within the next decade.
自 40 年前首例通过体外受精孕育的婴儿诞生以来,生育治疗和辅助生殖技术已经帮助许多夫妇实现了生育目标。目前,对于无法产生功能性精子的男性,还没有可行的生育选择,但许多实验性疗法在动物模型中已经显示出了有前景的结果。对于生育能力低下的动物,恢复精子生成的方法有自体的(干细胞移植、从头形成和睾丸组织移植)和体外的(异种移植和体外精子发生),其成功率也各不相同。一旦确定了安全性概况并选择了理想的患者人群,这些技术中的一些可能很快就会准备好进行人体试验,很可能在未来十年内实现临床应用。